ReNerve Ltd. is a medical device company focused on the repair of peripheral nerve injuries. The firm is focused on commercializing medical devices and tissue engineering products that address significant unmet needs in peripheral nerve damage patients. The company is also developing tissue-based products for peripheral nerve repair and replacement and other related soft tissue surgical procedures. The company is focused on developing products that accelerate tissue regeneration while preventing scarring and negative inflammatory responses. Its products include NervAlign Nerve Cuff, NervAlign Nerve Graft and NervAlign Bionic Nerve. NervAlign Nerve Cuff is a soft, tissue compatible protective wrap used to protect repaired injured nerves. The company consists of a pliable scaffolding material that can be wrapped around the nerve, protecting surgical repairs and conforming to the nerve’s final shape, allowing regeneration to occur.
Follow-Up Questions
¿Quién es el CEO de ReNerve Ltd?
Dr. Julian Chick es el Chief Executive Officer de ReNerve Ltd, se unió a la empresa desde 2016.
¿Qué tal es el rendimiento del precio de la acción RNVEF?
El precio actual de RNVEF es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de ReNerve Ltd?
ReNerve Ltd pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de ReNerve Ltd?
La capitalización bursátil actual de ReNerve Ltd es $0
